Clinical trial
A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive…
NCT00363896 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00363896 |
|---|---|
| Title | A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) |
| Official title | Clinical Trial Assessing Efficacy and Safety of LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease (COPD) |
| Intervention type | Drug |
| Interventions | Aclidinium bromide, Placebo |
| Enrollment | 843 |
| Start date | Jul 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Aug 15, 2006 |
| Last update posted | Jan 6, 2017 |
| Countries | Andorra, Austria, Belgium, Bulgaria, Czechia, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland and 4 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: